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Purpose: The purposes of this study were to estimate the distribution of three levels of risk for developing
coronary heart disease (CHD; low, moderate, and high risk) and to evaluate the attainment of cardio-
vascular disease prevention guideline goals by the American Heart Association in a nationally repre-
sentative sample of Korean women.
Methods: This is a secondary data analysis study using the data set from the 2008 Korea National Health
and Nutrition Examination Survey IV. The sample was 3,301 Korean women (representing 15,600,514
women) older than 20 years without cardiovascular disease. Distribution of CHD risk and level of goal
attainment were calculated using sampling weights and presented in percentages.
Results: Among Korean women without established cardiovascular disease, 7.9% were at high risk for
CHD, 20.5% were at moderate risk, and 71.6% were at low risk. The proportion of Korean women who did
not meet their goals was substantial, and most women at high risk remained unmanaged for their high
blood lipids.
Conclusion: Korean women at risk for developing CHD need to be managed as soon as possible to attain
the guideline goals and to lower their risk for future CHD. Aggressive risk reduction efforts are urgently
needed to reduce the public burden of CHD in Korean women.
Copyright  2012, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.Introduction
Over the past two decades, mortality from coronary heart
disease (CHD) has increased about tenfold in Koreanwomen (Korea
National Statistical Ofﬁce, 2010). Furthermore, it is estimated that
such epidemics will continue due to prolonged life expectancy and
unhealthy changes in lifestyles (H. M. Kim, Kim, Jung, Park, & Park,
2007; Lee et al., 2007). Notably, CHD has become a signiﬁcant
burden in Korean women. As such, primary prevention efforts are
crucial in this population.
CHD is relatively difﬁcult to evaluate in women, thus requiring
special attention for primary prevention. Evidence regarding
gender differences in CHD has shown that women differ from men
in their symptom manifestation, pathophysiology, and prognosis
of CHD (Bellasi, Raggi, Bairey Merz, & Shaw, 2007; Lee et al., 2008;
Quyyumi, 2006; Reis et al., 2001). Unlike men, women frequently
do not complain of typical symptoms of CHD (Lee et al.). The onset, Department of Physiological
ancisco, CA 94143-0610, USA.
rean Society of Nursing Science. Pof CHD in women is about 10e15 years later than in men (Lee
et al.). Because of their atypical symptoms and later onset of the
disease, the diagnosis of CHD in women can be more difﬁcult.
Furthermore, in women cholesterol plaques spread thinly through
the artery wall rather than forming major blockages (Reis et al.). In
this condition, which is termed coronary microvascular syndrome,
plaques accumulate in the tiny cardiac arteries thus limiting blood
ﬂow to the heart. It can cause myocardial ischemia, but the plaque
is often not visible with diagnostic coronary angiography
(Quyyumi; Reis et al.). As a result, CHD in women often goes
unrecognized and unmanaged. However, once clinical CHD has
developed, women have a worse prognosis than men (Bellasi et al.;
Lee et al.); more women die from a ﬁrst heart attack (Lee et al.).
Therefore, aggressive primary prevention of CHD is crucial espe-
cially in women.
Fortunately, primary prevention of CHD in women is effective
(Brugts et al., 2009; Maruthur, Wang, & Appel, 2009; Stampfer, Hu,
Manson, Rimm, & Willett, 2000). Risk reduction through improved
control of risk factors and therapeutic lifestyle changes is a central
strategy for preventing CHD. Nurses play an important role in
primary care such as assessing risk factors and CHD risk as well as
providing behavioral interventions and education. Thus, nursesublished by Elsevier. All rights reserved.
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assessment and risk reduction in women. American Heart Associ-
ation (AHA) evidence-based clinical guidelines are available to
assist in accurate assessment of CHD risk and to provide appro-
priate therapeutic goals based on risk (Pearson et al., 2002).
Adherence to empirically validated clinical guidelines may make it
possible to achieve the highest possible levels of CHD risk
reduction.
The purposes of this study were to estimate the distribution of
three levels of risk for developing CHD (low, moderate, and high
risk) and to evaluate the level of guideline goal attainment rec-
ommended by the AHA in a nationally representative sample of
Korean women who are free of cardiovascular disease (CVD) in
order to determine the proportion of Korean women who are in
need of preventive care.
Methods
Design and data source
This is a secondary data analysis using data from the 2008
Korea National Health and Nutrition Examination Survey IV
(KNHANES IV) collected by the Korea Centers for Disease Control
and Prevention (KCDC). The KNHANES, an ongoing program of the
KCDC, is a series of independent, nationally representative surveys
that have been conducted periodically since 1998. The present
study used the data set from the 2008 KNHANES IV because not
only was it the latest data set available, but also, each individual
within the selected households in the 2008 survey was inter-
viewed separately rather than by obtaining a proxy interviewwith
the household reference person. In addition, to encourage and
facilitate participation, compensation (snacks and KRW 10,000)
was given to each participant, and a mobile center which traveled
to locations throughout the country was introduced as a new
feature in 2008 so the response rate was improved in 2008 (74.3%;
KCDC, 2008).
Sample
The KNHANES IV collected data from a representative sample of
Koreans using a stratiﬁed, multistage probability sampling design
based on the 2005 census data (KCDC, 2008). The urban and rural
areas of 29 administrative districts were ﬁrst taken as strata. From
the strata, 200 national districts were taken as primary sampling
units based on proportional random sampling. Lastly, 20e23
households were sampled from each unit, and all family
members older than 1 year old in the selected households took part
in the KNHANES IV. The sample for this study was limited to
women who completed the survey, did not have established CVD,
and were older than 20 years. Age at 20 years was chosen because
the AHA recommends that CHD risk assessment and risk reduction
in women begin at age 20 years. To deﬁne established CVD, self-
reported heart attack, angina pectoris, or stroke were used.
Women who were pregnant or breast-feeding were excluded
because pregnancy or breast-feeding may affect body mass index
(BMI), blood pressure (BP) or blood sugar. To determine if a woman
was pregnant or breast-feeding, self-reported pregnancy or breast-
feeding was used.
Of the total of 5,374 women participants in the KNHANES IV,
4,100 women were older than 20 years. After applying inclusion/
exclusion criteria, 3488 womenwere eligible for this study. Among
these women, 110 women did not fast for at least 8 hours prior to
blood tests or did not answer the question about number of fasting
hours, making glucose and lipid levels unreliable. Mean substitu-
tions for glucose and lipid levels for those 110 women wereconsidered, but substituting means for glucose and lipid levels did
not change the ﬁnal results signiﬁcantly. Also, because those 110
women did not differ in demographics and other cardiovascular
risk factors from those who fasted for more than 8 hours, they were
excluded from the analysis of this study. Twenty-six women had
one or more items missing on physical activities questions. Those
with missing data did not differ from those without missing data in
terms of demographics and cardiovascular risk factors, so the 26
women were also excluded from the analysis. In the original study,
the lipid proﬁle did not include low-density lipoprotein cholesterol
(LDL-C) directly, so in this study LDL-C was estimated by the Frie-
dewald equation (LDL ¼ total cholesterol e high-density lipopro-
tein [HDL] e triglycerides/5). The equation is unreliable and invalid
for those with triglycerides at 400 mg/dL or greater (Friedewald,
Levy, & Fredrickson, 1972). Fifty-one women had triglyceride
levels at 400 mg/dL or greater. Therefore, these women were




Demographics such as marital status, educational level, work
status, and monthly household income were included in this study
to describe sample characteristics. In particular, there is no ofﬁcial
poverty line in Korea so the concept of poverty income ratios was
used to deﬁne poverty level for this study. The poverty income
ratios represents the ratio of family income adjusted by family size
to the poverty threshold, which is based on the minimum cost of
living set by the Ministry of Health andWelfare (KRW 1,400,000 for
a household of 4 people per month; approximately USD 1,300 per
month). Ratios below 1 indicate that the income for the respective
family is below the poverty threshold, and were therefore consid-
ered as being below the poverty level.
CHD risk assessment
According to the AHA guidelines, CHD risk assessment is based
on the number of cardiovascular risk factors and a 10-year risk
using the Framingham Risk Score (FRS; Figure 1). Diabetes is
considered to be a CHD equivalent for risk classiﬁcation purposes. In
this study, diabetes was deﬁned as a self-reported previous history
of diabetes, use of glucose lowering medications, or a fasting blood
glucose  126 mg/dL (American Diabetes Association, 2010). Those
with diabetes were considered at already high risk for CHD.
Age was measured in years; an age of 55 years or greater was
considered a risk factor for CHD. Participants were considered
current smokers if they reported that they were currently
smoking. BPs were obtained three times, and the average of the
second and third BPs was used for this study as recommended by
the Joint National Committee 7 (Chobanian et al., 2003). Partici-
pants were also asked whether they were currently on antihy-
pertensive medications. Hypertension was deﬁned as a systolic or
diastolic BP  140/90 mmHg or the use of antihypertensive
medications (Chobanian et al.). Blood samples were collected after
8 hours of fasting, and blood glucose and lipid levels were
analyzed in a national laboratory. An HDL-C level of less than
50 mg/dL is considered low and was counted as a risk factor for
CHD; if HDL-C is greater than 60 mg/dL, 1 was subtracted from the
risk factor count. It should be noted that family history was not
available in the original data set. Thus, only four risk factors
excluding family history were used in the risk factor count to
assess CHD risk in this study. For those with two or more risk
factors, the FRS was calculated using the downloadable spread-
sheet calculator (National Heart Lung Blood Institute, 2010). It
estimates an individual’s risk of having a ﬁrst heart attack in the
Figure 1. American Heart Association evidence-based guidelines for CVD prevention in women. Adapted from “AHA guidelines for primary prevention of cardiovascular disease
and stroke,” by Pearson et al., 2002, Circulation, 106, p. 388-391. CVD ¼ cardiovascular disease; RF ¼ risk factor; BP ¼ blood pressure; FRS ¼ Framingham Risk Score; HDL-C ¼ high-
density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein cholesterol.
S. Boo, E.S. Froelicher / Asian Nursing Research 6 (2012) 49e54 51next 10 years using seven variables: age, sex, total cholesterol,
HDL-C, smoking status, systolic BP and the subjects’ use of
medication to control hypertension.
Goal attainment
In this study, goal attainment was based on the AHA guideline
goals for CVD prevention in women. According to the AHA guide-
lines, the goal for LDL-C levels is determined based on the CHD risk
assessed (Figure 1). LDL-C was not directly measured in the original
study, so it was estimated with the Friedewald equation. BMI was
calculated from the formula of weight in kilograms divided by
height in meters squared (kg/m2). Overweight/obesity was deﬁned
as BMI at 23 kg/m2 or greater in this study on the basis of the Asian-
Paciﬁc region of the World Health Organization (2000). Waist
circumference was measured in centimeters, and abdominal
obesity was deﬁned as a waist circumference of 85 cm or greater as
suggested by the Korean Society for the Study of Obesity (Lee et al.,
2007).
Physical activity was self-reported with the Korean version of
the International Physical Activity Questionnaire (IPAQ) (Craig et al.,
2003). Subjects were asked to recall the frequency, duration, and
intensity of physical activity engaged in for at least 10 minutes in
the past 7 days. Data collected with the IPAQ were scoredin metabolic equivalent-minutes/week (1 MET ¼ 3.5 mL of oxygen
uptake per kg per minute) for this study (IPAQ, 2003). Engaging in
at least 30 minutes of moderate activity on most or preferably all
days of the week can help to prevent CHD. This amount of physical
activity is approximately 600 MET-minutes/week (IPAQ). Women
with less than 600 MET-minutes/week were considered sedentary
in this study. The IPAQ, when developed, showed acceptable reli-
ability (Spearman’s rho ¼ .67) and criterion validity (compared to
the accelerometer) for 20 diverse countries, comparable to most
other self-report physical activity questionnaires (Craig et al.). The
reliability and validity of the Korean version of IPAQ showed similar
results (Oh, Yang, Kim, & Kang, 2007).
Statistical analysis
The SPSS Complex Samples 19.0 (SPSS Inc., Chicago, IL, USA) was
used for statistical analysis of this descriptive study. All study
variables were screened for missing data, outliers, and suspected
errors. To account for the study’s multistage stratiﬁed sampling
design and to estimate population-based results, sampling weights
were applied for the analysis of this study so the estimates were
representative of Koreanwomen.Weightedmeans and percentages
were presented to describe demographic characteristics,
Table 2 Distribution of Coronary Heart Disease Risk in Korean Women
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not attain CVD prevention guideline goals.Risk groups n Weighted n % (SE)
Low riska 2,123 11,176,329 71.6 (0.9)
Moderate riskb 867 3,196,939 20.5 (0.9)
High riskc 311 1,227,246 7.9 (0.5)
Total 3,301 15,600,514 100.0 (0.0)
Notes. SE ¼ standard error; FRS ¼ Framingham Risk Score.
a Low risk refers to one or less risk factor among hypertension, high-density
lipoprotein level < 50 mg/dL, age  55 years, and cigarette smoking.
b Moderate risk refers to two or more risk factors listed and FRS < 20%.
c High risk refers to two or more risk factors listed and FRS  20% or diabetes.Ethical aspects
The original survey was approved by the KCDC institutional
review board. This study used only de-identiﬁed existing data with
no subject contact. Permission to conduct this study was approved
by the University of California San Francisco Committee on Human
Research. The SPSS data set and the data directory were directly
downloaded from the KCDC website (http://knhanes.cdc.go.kr/),
and downloaded electronic data were protected with a password.Results
Demographic characteristics and cardiovascular risk factors of
Korean women are presented in Table 1. The sample of this study
represents 15,600,514 Korean women older than 20 years with
aweightedmean age of 47.7 years. Table 2 shows the distribution of
three risk categories among Korean women, based on the AHA
guidelines for CVD prevention. About 8% of the Korean women
were categorized as high risk for future cardiac events, 20.5% were
moderate risk, and 71.6% were low risk. An evaluation of the risk for
developing CHD by age groups was graphically depicted in Figure 2.
The proportion of moderate or high risk women increased espe-
cially after age 50. More than 80% of Korean women older than 60
years had at least two cardiovascular risk factors for CHD, and less
than 20% were at low risk for CHD. In addition, even for Korean
women in their 20s, approximately 1 in 100was categorized as high
risk for developing CHD.
The percentages of Korean women who did not attain the CVD
prevention guideline goals are presented in Table 3. Overall, 18.3%
of Korean women did not meet the primary goal of LDL-C. Lack ofTable 1 Demographic Characteristics and Cardiovascular Risk Factors in Korean
Women (n ¼ 3,301, Weighted n ¼ 15,600,514)
Demographics or cardiovascular risk factors M or % (SE) Range
Age (yr) 47.7 (0.4) 20.0-93.0
Marital status (married & living together) 67.3 (1.1) -
Education (high school or less) 75.5 (1.1) -
Employed (n ¼ 3,296) 47.0 (1.1) -
Below poverty level (n ¼ 3,208)a 23.7 (1.0) -
Blood lipids
Diagnosed dyslipidemia 6.1 (0.5) -
Lipid-lowering treatment 2.8 (0.3) -
Total cholesterol (mg/dL) 186.2 (0.8) 95.0-449.0
LDL-C (mg/dL) 113.9 (0.7) 17.8-316.0
HDL-C (mg/dL) 51.0 (0.3) 22.8-106.2
Triglycerides (mg/dL) 106.4 (1.4) 18.0-398.0
Blood pressure -
Diagnosed hypertension 15.8 (0.7) -
Hypertension treatment 14.1 (0.7) -
Systolic BP (mmHg) 111.8 (0.4) 74.0-224.0
Diastolic BP (mmHg) 72.5 (0.3) 36.0-153.0
Blood glucose
Diagnosed diabetes 5.9 (0.4) -
Diabetes treatment 4.6 (0.4) -
Fasting blood sugar (mg/dL) 96.1 (0.5) 43.0-398.0
Current smoking 7.3 (0.6) -
Body mass index (kg/m2) 23.1 (0.1) 15.3-40.5
Waist circumference (cm) 78.1 (0.3) 46.2-127.0
Physical inactivityb 33.5 (1.2) -
Notes. SE ¼ standard error; LDL-C ¼ low-density lipoprotein cholesterol; HDL-
C ¼ high-density lipoprotein cholesterol; BP ¼ blood pressure; MET ¼ metabolic
equivalent.
a Below poverty level refers to a poverty-income ratio of less than 1.
b Physical inactivity refers to MET-minutes/week < 600.goal attainment was most prevalent in the high risk group. About
three in four women in the high risk group did not meet the
primary goal of LDL-C less than 100 mg/dL. More than 70% of high
risk women had HDL-C levels lower than the recommended levels;
less than half (48.3%) had their blood pressure controlled; only
14.5% had fasting blood sugar levels less than 100mg/dL; about one
in four maintained their weight within normal range; and more
than half were centrally obese. For the moderate risk group, the
recommended LDL-C goal is less than 130 mg/dL, and 40.3% of
women in this risk group were not at the LDL-C goal level.
Discussion
This study evaluated the distribution of CHD risk in Korean
women and the attainment of CVD prevention guideline goals by
the AHA. Based on the numbers of risk factors and the FRS, 7.9% of
Korean women (representing 1,227,246 women) without estab-
lished CVDwere at high risk for CHD; 20.5% (representing 3,196,939
women) were at moderate risk; and 71.6% (representing 11,176,329
women) were at low risk. It should be noted that in this study,
family history was not available in the original data set, thus only
four risk factors excluding family history were used in the risk
factor count. Such data may underestimate the true proportion of
Korean women at moderate risk and overestimate the low risk
group but should not affect the high risk group.
Evidence has shown that risk reduction signiﬁcantly reduces
mortality from CHD in asymptomatic women (Brugts et al., 2009;
Cannon et al., 2004). Although the beneﬁts of risk reduction are
well identiﬁed, Korean women showed a lack of goal attainment.
Overall, 18.3% of Koreanwomen free of CVD were not at LDL-C goal
levels and were therefore in need of treatment to prevent future
cardiac events. Although the beneﬁts of risk reduction are greatest
in those at high risk, unfortunately goal attainment was the worst
in Korean women at high risk. Three in four high risk women didFigure 2. Distribution of risk for coronary heart disease among Korean women aged 20
years or older by age group (n ¼ 3,301).
Table 3 Proportions of Korean Women Who Did Not Attain Cardiovascular Disease Prevention Guideline Goals by Risk Groups
Goals % (95% CI)
Low risk (n ¼ 2,123) Moderate risk (n ¼ 867) High risk (n ¼ 311) Total (n ¼ 3,301)
Blood lipids
High LDL-Ca 5.6 (4.7, 6.8) 40.3 (36.3, 44.4) 74.6 (68.5, 79.8) 18.3 (16.8, 19.8)
HDL-C < 50 mg/dL 35.9 (33.5, 38.4) 87.3 (84.0, 89.9) 70.6 (63.8, 76.6) 49.2 (47.1, 51.4)
Triglycerides  150 mg/dL 10.4 (9.0, 11.9) 36.3 (32.3, 40.4) 48.2 (41.5, 54.9) 18.7 (17.2, 20.3)
Lipid-lowering treatment 1.2 (0.8, 1.8) 5.5 (4.1, 7.4) 10.6 (7.5, 14.7) 2.8 (2.3, 3.5)
High BPb 4.1 (3.3, 5.3) 26.6 (23.3, 30.1) 51.7 (45.5, 57.8) 12.6 (11.4, 13.8)
Fasting blood sugar  100 mg/dL 13.1 (11.5, 14.8) 28.4 (24.7, 32.3) 85.5 (80.8, 89.2) 22.0 (20.4, 23.7)
HbA1c  7% c e e 52.0 (48.0, 54.8) 52.0 (48.0, 54.8)
Current smoking 5.2 (4.0, 6.7) 15.8 (12.4, 20.0) 4.0 (2.3, 6.8) 7.3 (6.1, 8.6)
Overweight/obesityd 39.4 (36.8, 42.1) 64.6 (60.3, 69.0) 72.2 (66.3, 77.4) 47.3 (45.0, 49.5)
Central obesitye 15.9 (14.0, 18.0) 43.3 (39.0, 47.8) 52.6 (45.7, 59.4) 24.4 (22.6, 26.4)
Physical inactivityf 31.9 (29.2, 34.7) 37.9 (33.3, 42.7) 37.0 (31.0, 43.4) 33.5 (31.3, 35.8)
Notes. CI¼ conﬁdence interval; LDL-C¼ low-density lipoprotein cholesterol; HDL-C¼ high-density lipoprotein cholesterol; BP¼ blood pressure; MET¼metabolic equivalent.
a High LDL-C refers to LDL-C 160 mg/dL for low risk group, LDL-C  130 mg/dL for moderate risk group, and LDL-C  100 mg/dL for high risk group.
b High BP refers to BP  140/90 mmHg, if diabetes is present BP  130/80 mmHg.
c Women with diagnosed diabetes (n ¼ 204).
d Overweight/obesity refers to body mass index  23 kg/m2.
e Central obesity refers to waist circumference  85 cm.
f Physical inactivity refers to MET-minutes/week < 600.
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need of aggressive and urgent lipid-lowering treatment; 70.6% had
HDL-C less than 50mg/dL; more than half had blood pressure levels
higher than the recommended levels; 85.5% had blood sugar at
100 mg/dL or greater; and 4.0% were current smokers. This is
a serious problem because their risk for future cardiac events is as
high as those with established CVD. Korean women at high risk
need to bemanaged as soon as possible to attain the guideline goals
and to lower their risk for future CHD accordingly.
LDL-C, the primary target for CHD risk reduction, can be
managed effectively through the use of lipid-lowering medications
and therapeutic lifestyle changes such as quitting smoking,
increasing physical activity, and maintaining a healthy diet for all
risk categories. However, for those at high risk, lifestyle changes
alone are often insufﬁcient to attain the LDL-C goal (Grundy et al.,
2004). Current guidelines recommend starting lipid-lowering
medications for those at high risk when asymptomatic individ-
uals do not meet the LDL-C goal of less than 100 mg/dL (Grundy
et al.). Previous studies found that use of lipid-lowering medica-
tions is the strongest predictor for the LDL-C goal attainment (Fuke
et al., 2004; Mosca et al., 2005). It is safe and beneﬁcial in reducing
cardiovascular mortality (Brugts et al., 2009; Cannon et al., 2004).
However, this study found a signiﬁcant treatment gap in Korean
women. Even though treatment rates increased with increased
cardiovascular risk, there was still substantial room for improve-
ment in lipid-lowering treatment among women at high risk. In
this study, only 10.6% of women in the high risk group were on
treatment to lower their blood lipids, and most Korean women at
high risk remained untreated. This is a signiﬁcant treatment gap,
given that 74.6% of high risk women were actually in need of lipid-
lowering treatment. Korean women are exposed to high risk for
future CHD even though there are relatively safe and effective
intervention strategies available as well as compelling evidence
showing reduction in CHDmortality with lipid-lowering treatment.
Furthermore, evidence suggests that for the high risk group, an
LDL-C level of less than 100 mg/dL is not an optimal goal but
a minimal goal to be attained (Cannon et al., 2004; Grundy et al.,
2004; Heart Protection Study Collaborative Group, 2002). Clinical
trials have shown that an LDL-C level lower than 100 mg/dL with
lipid-lowering medications further reduces relative risk for CHD
(Cannon et al.; Heart Protection Study Collaborative Group). The
trials also showed that reducing LDL-C to 70 mg/dL in the high risk
group would produce another 16e30% of risk reduction comparedto LDL-C at 100 mg/dL. For the high risk group, an LDL-C level of
100 mg/dL should be viewed as a minimal goal to be attained. For
maximum beneﬁt, an LDL-C level of less than 70 mg/dL is recom-
mended. In this study, when applying the cut-points of LDL-C less
than 70 mg/dL, only 3.9% of women in the high risk group attained
this level. This suggests that lipid-lowering treatment is not optimal
for Koreanwomen free of CVD, and there is substantial opportunity
to improve lipid management.
Suboptimal lipid-lowering treatment in Korean women may be
related to several factors. This study found that LDL-C goal attain-
ment was the worst in women at high risk even though the
proportion of women taking lipid-lowering medications was the
highest in this group, and on average, LDL-C in the high risk group is
lower than that of women at moderate risk. One possible expla-
nation for this ﬁnding is that the intensity of risk reduction is
always risk-based, so those at higher risk need more aggressive
therapy. Because of the central role of LDL-C in the development of
CHD, the LDL-C goal for the high risk group is more stringent than
other risk groups. Therefore, those at high risk require more
aggressive lipid management efforts to effectively reduce their
increased risk. Another possibility that may explain the treatment
gap is that Korean women lack knowledge about blood lipids and
their role in the development of CHD. A study showed that the
majority of middle-aged Koreanwomen failed to recognize lipids as
risk factors for CHD, and about 95% of women did not know their
blood lipid levels (Choi et al., 2010). Lack of awareness of blood
lipids may impede risk reduction efforts to lower lipids, leading to
suboptimal lipid-lowering treatment and lack of LDL-C goal
attainment.
Although LDL-C is the primary target for CHD prevention,
therapeutic lifestyle changes are the ﬁrst recommended strategy by
AHA for preventing CHD in all asymptomatic individuals.
Unhealthy lifestyles, if they persist for a long time, convey
substantial risk for CHD. However, the ﬁndings of this study imply
that the proportion of Korean women engaged in healthy lifestyles
is very small. About 7.3% of women were current smokers; one in
three women was sedentary; about half of Korean women were
overweight; and 24.4% were centrally obese. In addition, 49.2% of
Korean women had low HDL-C levels, which are suggested to be
related to excess carbohydrate intake and a sedentary lifestyle (M.
H. Kim, Lee, Park, & Kim, 2007; W. Y. Kim, Kim, Choi, & Huh, 2008).
Facilitating an effective intervention to motivate women to be
active, maintain their weight, and eat a heart-healthy diet may put
S. Boo, E.S. Froelicher / Asian Nursing Research 6 (2012) 49e5454a brake on the current epidemic rise of CHD in Korea. It should be
a priority in reducing the public burden of CHD.
There are several issues that may have affected the accuracy of
the ﬁndings of this study. The KNHANES IV used a probability
sampling design but the sampling frame excluded institutionalized
individuals. The ﬁndings from the survey can be interpreted as
representative of the community-dwelling population. Self-
reported data may be subject to response bias, especially for
questions about smoking status. Because of the strong social taboo
against women smoking in Korea, participantsmay have responded
in a socially desirable way, so the risk for CHD may be under-
estimated. However, the strengths of this study are well-
established methods and procedures, and large randomly
selected representative sample. In addition, estimates were calcu-
lated using the sampling weights, so the estimates are represen-
tatives of noninstitutionalized Korean women.
Conclusion
The most important ﬁnding of this study is that the proportion
of Korean women who were not at the AHA guideline goals was
substantial. Furthermore, most Korean women at high risk
remained unmanaged for their high blood lipids. The ﬁndings of
this study suggest that, on the basis of the AHA evidence-based
guidelines for CVD prevention, Korean women free of CVD need
to be managed more aggressively to control their cardiovascular
risk factors. Also, facilitating effective interventions that motivate
Korean women to adopt healthy lifestyles, including quitting
smoking, having regular physical activity, and maintaining
a healthy weight, is urgent. Nurses in all settings are well posi-
tioned and should be active in advising women to change
unhealthy lifestyles.
In addition, suboptimal goal attainment can be related to several
factors such as age, comorbid diseases, socioeconomic status,
treatment status, or nonadherence to treatment guidelines by
physicians or lack of adherence by patients. This study did not
attempt to identify the variables related to the lack of goal attain-
ment. Further research is warranted to identity predictors of lack of
goal attainment in order to help Korean women effectively reduce
their risk for future cardiac events.
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